<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, since the current testing capacity by conventional PCR based methods is insufficient due of shortages of global supplies such as RNA extraction kits and PCR reagents, alternative and/or complementary testing assays should be developed. Here, we suggest that targeted and untargeted MS-based multiplexing technologies could have potential to accelerate the understanding of the complexity of COVID-19 pandemic and its management.</p>
